Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-... NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.16 | -7.23981900452 | 2.21 | 2.25 | 1.95 | 199545 | 2.07766346 | CS |
| 4 | -0.28 | -12.017167382 | 2.33 | 2.475 | 1.84 | 205854 | 2.13882137 | CS |
| 12 | -0.06 | -2.84360189573 | 2.11 | 6.01 | 1.84 | 947018 | 3.46835153 | CS |
| 26 | 0.37 | 22.0238095238 | 1.68 | 6.01 | 1.1 | 663238 | 2.84842754 | CS |
| 52 | -3.331 | -61.9029920089 | 5.381 | 6.01 | 1.1 | 466513 | 3.01323388 | CS |
| 156 | -25.55 | -92.5724637681 | 27.6 | 29.6 | 1.1 | 847617 | 5.94944591 | CS |
| 260 | -228.05 | -99.1090830074 | 230.1 | 262.4 | 1.1 | 1337090 | 63.86204832 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
